J. N. King

发表

Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo‐Controlled Clinical Trial

J. Rousselot, W. Seewald, U. Bonfanti, 2017, Journal of veterinary internal medicine.

Tolerability and efficacy of benazepril in cats with chronic kidney disease.

S. Tasker, D. Gunn-Moore, G. Strehlau, 2006, Journal of veterinary internal medicine.

Evaluation o f t he Clinical E fficacy o f B enazepril in the T reatment of Chronic Renal I nsufficiency in Cats

H. Kitagawa, H. Mizutani, H. Koyama, 2006 .

Tolerability and E fficacy o f B enazepril in Cats with Chronic Kidney D isease

D. Gunn-Moore, J. N. King, A. Gleadhill, 2006 .

Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.

H. Kitagawa, H. Mizutani, H. Koyama, 2006 .

Efficacy and acceptability of the new oral phosphate binder Lenziaren(®) in healthy cats fed a renal diet.

J. King, H. Luus, J. N. King, 2015, Journal of veterinary pharmacology and therapeutics.

Benazepril increases feed intake and body weight in healthy growing cats.

W. Seewald, J. N. King, E. Goldenthal, 2006, Journal of veterinary pharmacology and therapeutics.

Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.

S. A. Brown, G. Strehlau, J. N. King, 2002, Journal of veterinary pharmacology and therapeutics.

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs

C. Thompson, S. King, D. Karadzovska, 2017, BMC Veterinary Research.

Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs

C. Thompson, S. King, D. Karadzovska, 2017, Journal of veterinary internal medicine.

Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.

P. Toutain, J. Elliott, P. Lees, 2014, Journal of veterinary pharmacology and therapeutics.

Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.

P. Toutain, J. Elliott, P. Lees, 2012, Journal of veterinary pharmacology and therapeutics.

Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial.

M. Okumura, W. Seewald, T. Sano, 2012, Veterinary journal.

Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.

J. Arnaud, P. Lees, M. Jung, 2011, Journal of veterinary pharmacology and therapeutics.

Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats.

J. Giraudel, P. Gruet, W. Seewald, 2010, American journal of veterinary research.

In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.

P. Lees, W. Seewald, J. N. King, 2010, Journal of veterinary pharmacology and therapeutics.

Angiotensin-converting enzyme inhibitors in veterinary medicine.

P. Toutain, S. A. Brown, V. Chetboul, 2007, Current pharmaceutical design.

Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.

G. Kaiser, C. Mauron, J. N. King, 1995, American journal of veterinary research.

Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.

P. Gruet, W. Seewald, J. N. King, 2012, Journal of veterinary pharmacology and therapeutics.

Prognostic factors in cats with chronic kidney disease.

S. Tasker, D. Gunn-Moore, G. Strehlau, 2007, Journal of veterinary internal medicine.

Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

J. Giraudel, W. Seewald, J. N. King, 2015, BMC Veterinary Research.

Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.

K. Edamura, M. Okumura, W. Seewald, 2012, The Journal of veterinary medical science.

Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial.

R. Nishimura, K. Yamashita, W. Seewald, 2012, Veterinary journal.

Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs.

G. Strehlau, J. N. King, C. Christinaz, 2018, Journal of veterinary pharmacology and therapeutics.

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib

P. Toutain, J. Giraudel, J. Elliott, 2022, Journal of veterinary pharmacology and therapeutics.

Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney

J. Elliott, H. Syme, P. Lees, 2015, BMC Veterinary Research.

Safety of oral robenacoxib in the cat.

D. Roth, P. Lees, W. Seewald, 2012, Journal of veterinary pharmacology and therapeutics.

Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.

P. Toutain, J. Giraudel, P. Lees, 2009, Journal of veterinary pharmacology and therapeutics.

Effects of clomipramine hydrochloride on heart rate and rhythm in healthy dogs.

P. Champéroux, S. Richard, J. Pouchelon, 2000, American journal of veterinary research.

Pharmacokinetics of clomipramine in dogs following single-dose intravenous and oral administration.

R. Hotz, J. N. King, R. Fisch, 2000, American journal of veterinary research.

Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration.

G. Strehlau, J. N. King, B. Altmann, 2000, American journal of veterinary research.

Bidirectional chiral inversion of the enantiomers of the nonsteroidal antiinflammatory drug oxindanac in dogs.

S. Hauffe, C. Mauron, J. N. King, 1994, Chirality.

Safety of a benazepril and pimobendan combination tablet in adult healthy dogs

J. Giraudel, G. Strehlau, J. N. King, 2018, Journal of veterinary pharmacology and therapeutics.

Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs

C. Désévaux, W. Seewald, J. N. King, 2017, Journal of veterinary pharmacology and therapeutics.

Correlation between the pharmacokinetics of oxindanac and inhibition of serum thromboxane B2 in calves.

J. N. King, 1994, Journal of veterinary pharmacology and therapeutics.

The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug.

J. N. King, 1993, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib.

P. Toutain, J. Giraudel, E. Jeunesse, 2009, Journal of Veterinary Pharmacology and Therapeutics.

Analytical determination and pharmacokinetics of robenacoxib in the dog.

P. Lees, M. Jung, W. Seewald, 2009, Journal of veterinary pharmacology and therapeutics.

Pharmacokinetic/pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats.

P. Toutain, J. N. King, M. Maurer, 2003, Journal of veterinary pharmacology and therapeutics.

Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach.

P. Toutain, H. Lefebvre, J. N. King, 2000, The Journal of pharmacology and experimental therapeutics.

Evaluation of injectable robenacoxib for the treatment of post-operative pain in cats: results of a randomized, masked, placebo-controlled clinical trial

S. King, E. Roberts, J. N. King, 2016, BMC Veterinary Research.

Evaluation of Oral Robenacoxib for the Treatment of Postoperative Pain and Inflammation in Cats: Results of a Randomized Clinical Trial

S. King, E. Roberts, J. N. King, 2012, ISRN veterinary science.

Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy Results of a prospective, open-label, multicenter clinical trial.

H. Schmidli, T. Glaus, C. Lombard, 1999, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Results of a follow-up investigation to a clinical trial testing the efficacy of clomipramine in the treatment of separation anxiety in dogs

K. Overall, D. Appleby, P. Pageat, 2004 .

Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats

C. Désévaux, W. Seewald, J. N. King, 2016, BMC Veterinary Research.

Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.

G. Strehlau, J. N. King, E. de Madron, 2011, The Canadian veterinary journal = La revue veterinaire canadienne.

Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl.

J. N. King, M. Maurer, E. Humbert-Droz, 1999, Journal of veterinary pharmacology and therapeutics.

Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.

G. Kaiser, C. Mauron, J. N. King, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases.

M W S Martin, M J Stafford Johnson, G Strehlau, 2010, The Journal of small animal practice.

High performance liquid chromatography and pharmacokinetics of the non-steroidal anti-inflammatory drug oxindanac in calves.

S. Hauffe, C. Le Goff, M. Voirol, 1994, Journal of veterinary pharmacology and therapeutics.

Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.

H. Kitagawa, H. Mizutani, H. Koyama, 2006, Journal of veterinary internal medicine.

Evaluation of the dose–response relationship of oral robenacoxib in urate crystal‐induced acute stifle synovitis in dogs

J. Peel, W. Seewald, L. Borer, 2017, Journal of veterinary pharmacology and therapeutics.

Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.

P. Lees, M. Jung, W. Seewald, 2010, Journal of veterinary pharmacology and therapeutics.

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.

P. Toutain, P. Lees, R. Fujimoto, 2009, Journal of veterinary pharmacology and therapeutics.

Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet

W. Seewald, J. N. King, P. Delport, 2014, BMC Veterinary Research.

Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs.

P. Gruet, W. Seewald, J. N. King, 2011, American journal of veterinary research.

Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.

K. Overall, Petit, D. Appleby, 2000, Applied animal behaviour science.

Determination of the dosage of clomipramine for the treatment of urine spraying in cats.

W. Seewald, S. Crowell‐Davis, J. Steffan, 2004, Journal of the American Veterinary Medical Association.

Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial

P. Gruet, W. Seewald, J. N. King, 2013, BMC Veterinary Research.

Clinical safety of robenacoxib in cats with chronic musculoskeletal disease

B. Lascelles, W. Seewald, S. Forster, 2021, Journal of veterinary internal medicine.

Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

B. Lascelles, M. Gruen, S. King, 2021, Scientific Reports.

Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial

S. Budsberg, B. Lascelles, S. King, 2016, Journal of feline medicine and surgery.

Population Pharmacokinetic Analysis of Blood and Joint Synovial Fluid Concentrations of Robenacoxib from Healthy Dogs and Dogs with Osteoarthritis

M. Peyrou, J. Giraudel, I. Letellier, 2010, Pharmaceutical Research.

Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis.

M. Fink, J. Mochel, M. Peyrou, 2013, Research in veterinary science.

Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats.

J. Giraudel, P. Gruet, W. Seewald, 2010, American journal of veterinary research.

Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed‐Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats

J. Mochel, A. Soubret, J. Elliott, 2016, CPT: pharmacometrics & systems pharmacology.

Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial

K. Simpson, L. Ferasin, C. Little, 2019, Journal of veterinary internal medicine.

Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.

P. Lees, M. Jung, W. Seewald, 2013, American journal of veterinary research.

Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.

J. Arnaud, P. Lees, M. Jung, 2011, Journal of veterinary pharmacology and therapeutics.

Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs.

P. Gruet, W. Seewald, J. N. King, 2011, American journal of veterinary research.

Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial

W. Seewald, S. Forster, A. Hirakawa, 2018, Journal of veterinary science.

Evaluation of cardiovascular effects of intravenous robenacoxib in dogs.

C. Désévaux, P. Champéroux, J. N. King, 2017, Journal of veterinary pharmacology and therapeutics.